Trukera Medical specializes in corneal health technologies, with a strong emphasis on tear osmolarity testing. Their flagship product, the ScoutPro® Osmolarity System, is designed to assess the osmolarity of tears, which is crucial for diagnosing and managing various ocular conditions. This system builds upon the foundation laid by the TearLab Osmolarity System, which has been utilized in over 24 million tests globally. The company aims to expand its offerings beyond osmolarity testing to address additional unmet medical needs in eye care, positioning itself as a comprehensive provider in the field of corneal health.

In addition to the ScoutPro® Osmolarity System, Trukera Medical is committed to advancing technologies that enhance the understanding and treatment of corneal health issues. The acquisition by Bausch + Lomb signifies a strategic alignment that enhances their capabilities in surgical, pharmaceutical, and vision care products. Trukera Medical's vision is to become the leading and most trusted name in corneal health, focusing on innovative solutions that improve patient outcomes and support eye care providers in their practices.

United States

Trukera Medical is a global leader in developing and marketing comprehensive corneal health technologies. The company introduced tear osmolarity testing to eye care with its flagship device, the TearLab Osmolarity System, which has been used over 24 million times worldwide. Trukera's expanding portfolio continues to focus on improving corneal health, both as a primary goal and in preparation for surgery. Get more details and new product announcements at www.trukera.com.

Trukera Medical

Company Details